FDA approves treatment for the control of bleeding episodes occurring in adults and adolescents 12 years of age and older with hemophilia A or B with inhibitors.
Read more: FDA Approves Additional Treatment for Adults and Adolescents with Hemophilia A or B and Inhibitors